BOLTNasdaq United States
Market cap
$7.782 M
$4.05 +4.65%
Close of 7 Aug 2026
Revenue
$7.70M
#3220 by revenue
Earnings
-$33.4M
Loss-making
Shares outstanding
1,921,567
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Where these numbers come from
Share counts and financials for Bolt Biotherapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.